News for Canntab Therapeutics Limited (CTABF)

Published at

Sep 18, 2023 7:45 PM

by marketscreener.com

neutral

neutral

Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

Canntab Therapeutics Limited announces that the Ontario Securities Commission has rejected the Corporation's application for a management cease trade order dated September 14, 2023, as the...

PILL.CN CTABF

Read more →
Published at

Nov 17, 2022 9:24 AM

by globenewswire.com

mixed

mixed

Medicinal Cannabis Market Size In 2022 (New Report) reaching USD 73952.26 million by 2027 With Impact of domestic and global market Top players: Manufacturers Data, Opportunity, Import Export Scenario

PUNE, Nov. 17, 2022 (GLOBE NEWSWIRE) -- "Medicinal Cannabis Market" research report focus on overall information that can help to take decisions on...

MXC.L MXC.AX MGCLF WEED.TO PILL.CN MJNA GWPRF GWPH CTABF CGC ACB.TO ACB 0UI4.L 0IT7.L

Read more →
Published at

Aug 5, 2022 3:20 PM

by benzinga.com

positive

positive

Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

WEED.TO TLRY.TO TLRY PILL.CN NWVCF ENW.V CURR CTABF CLCFF CLC.CN CGC APHA.TO APHA 0Z6Y.L 0UI4.L

Read more →
Published at

Aug 2, 2022 7:05 PM

by prnewswire.com

mixed

mixed

CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN)(OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

CTABF PILL.CN

Read more →
Published at

Jun 30, 2022 10:30 PM

by prnewswire.com

mixed

mixed

Canntab Corporate Update

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

CTABF PILL.CN

Read more →
Published at

May 30, 2022 10:05 PM

by prnewswire.com

mixed

mixed

CANNTAB ANNOUNCES CHANGE OF AUDITOR

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

CTABF PILL.CN

Read more →
Published at

Apr 13, 2022 1:11 PM

by prnewswire.com

positive

positive

Canntab Engages Hamish Sutherland as Strategic Advisor

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene...

WEED.TO PILL.CN NDVA.V CTABF CGC

Read more →
Published at

Mar 23, 2022 2:35 PM

by benzinga.com

positive

positive

Canntab Therapeutics Signs Affiliate Agreement With OnPharm-United

Canntab Therapeutics Limited (OTCQB:CTABF) (CSE:

PILL.CN CTABF

Read more →
Published at

Mar 23, 2022 12:49 PM

by prnewswire.com

positive

positive

CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and...

PILL.CN CTABF

Read more →
Published at

Feb 7, 2022 1:22 PM

by marketscreener.com

positive

positive

CANNTAB SIGNS HISTORIC AGREEMENT WITH FIRST NATIONS GROWERS GP INC. TO ADDRESS THE OPIATE AND ILLICIT DRUG CRISIS AFFECTING INDIGENOUS PEOPLES THROUGHOUT CANADA

TORONTO, Feb. 7, 2022 /PRNewswire/ - Canntab Therapeutics Limited , a leading innovator of cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce a... | February 7, 2022

PILL.CN CTABF

Read more →
Published at

Jan 10, 2022 7:55 PM

by benzinga.com

mixed

mixed

Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids - Levitee Labs (LVTTF)

Wellness company Levitee Labs Inc. (CSE:LVT) (OTC:

PILL.CN LVTTF CTABF LVT.CN

Read more →
Published at

Jan 10, 2022 2:04 PM

by financialpost.com

positive

positive

Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into…

PILL.CN LVTTF LVT.CN HEMP CTABF APAJF

Read more →
Published at

Feb 2, 2021 4:52 PM

by investingnews.com

positive

positive

Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets

Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab”) is thrilled to announce the Canadian Intellectual Property Office (“CIPO”) has allowed Canadian Patent No. CA 3050150 to Canntab.

TBF1.F PILL.CN CTABF

Read more →